In summary, it was revealed that eriodictyol treatment suppressed the clone-forming, proliferative, migratory and invasive abilities of CRC cells as well as repressed EMT process by downregulating TSTA3 expression to restrain fucosylation. Here, GFUS is linked to colorectal carcinoma.